Latest News on the Ultrasound Transducer Market (2026)
April 2026: GE HealthCare Launches Next Generation LOGIQ Ultrasound Systems
GE HealthCare announced on April 25, 2026 the introduction of its next-generation LOGIQ general imaging ultrasound systems, an intelligently designed portfolio built to elevate clinical imaging, accelerate workflows, and unlock deeper diagnostic insight. The launch reinforces accelerating premiumization and AI integration across general imaging applications, supporting durable expansion and competitive innovation across the global ultrasound transducer market, as reported by Imaging Technology News.March 2026: GE HealthCare and Medtronic Integrate Intraoperative Ultrasound
GE HealthCare and Medtronic announced a digital integration between the bkActiv intraoperative ultrasound system and the Stealth AXiS surgical navigation platform on April 9, 2026, enabling real-time imaging during cranial procedures. The plug-and-play visualization solution reinforces accelerating adoption of advanced surgical ultrasound transducers and supports durable expansion across the global ultrasound transducer market amid rising minimally invasive neurosurgery volumes, according to Yahoo Finance.March 2026: Butterfly Network Receives FDA Clearance for AI-Powered Pregnancy Ultrasound Tool
According to the US FDA clearance, Butterfly Network received approval for its AI-powered ultrasound pregnancy tool in March 2026. The clearance expands the use of portable ultrasound solutions in maternal care and supports broader access to pregnancy assessment in underserved healthcare settings globally.January 2026: ASUS Secures FDA Clearance for LU800 Handheld Ultrasound System
According to the US FDA clearance, ASUS obtained approval for its LU800 handheld ultrasound system in January 2026. The clearance strengthens portable diagnostic imaging capabilities and supports wider adoption of handheld ultrasound systems across clinical and point-of-care healthcare environments.Key Market Trends and Insights
- By end user, the hospitals segment is likely to dominate with 54% share in the historical period.
- By application, the cardiovascular imaging segment is expected to lead with 29% market share in the historical period.
- By geography, the Asia-Pacific region is likely to dominate with 32% revenue share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 4.51 Billion
- Projected Market Size (2035): USD 6.36 Billion
- CAGR (2026-2035): 3.50%
Ultrasound Transducer Market Overview
The market is witnessing steady growth, driven by rising demand for advanced diagnostic imaging and increasing prevalence of chronic diseases. Technological advancements in high-resolution imaging and portable devices are enhancing clinical efficiency. Expanding applications across cardiology, obstetrics, and emergency care further support adoption. Growing healthcare infrastructure and early disease detection initiatives are accelerating global market expansion. The market reached a value of approximately USD 4.51 Billion in 2025.Ultrasound Transducer Market Growth Drivers
Rising Diagnostic Demand and Expanding AI Integration in Imaging Systems Poised to Drive Market Demand
The increasing prevalence of chronic diseases, rising demand for early-stage diagnosis, and growing adoption of advanced imaging technologies are key market drivers supporting ultrasound transducer adoption. Expanding need for point-of-care diagnostics and improved maternal healthcare access further strengthen demand. For instance, in March 2026, Butterfly Network received FDA clearance for its AI-powered pregnancy ultrasound application, enabling broader clinical use of portable ultrasound transducers across underserved and remote healthcare settings. This advancement is expected to significantly enhance diagnostic accessibility, improve workflow efficiency, and accelerate adoption of compact imaging solutions during the forecast period.Ultrasound Transducer Market Trends
Key trends shaping the market include rising adoption of portable devices, AI integration, and advancements in high-resolution imaging technologies globally.Portable Imaging Advancements and Handheld Ultrasound Adoption Boosting the Market Landscape
Rising demand for decentralized healthcare delivery, increasing preference for rapid bedside diagnostics, and growing need for cost-efficient imaging solutions are key market drivers shaping ultrasound technology evolution. Expanding use of portable devices in emergency care and outpatient settings further reinforces this trend. For instance, in January 2026, ASUS received FDA clearance for its LU800 handheld ultrasound system, supporting wider clinical adoption of handheld ultrasound devices across hospitals and point-of-care environments. This development is expected to improve diagnostic efficiency, enhance accessibility, and accelerate the shift toward portable imaging systems during the forecast period.Ultrasound Transducer Market Segmentation
Market Breakup by Product
- Convex
- Linear
- Endocavitary
- Phased array
- CW Doppler
- Others
Market Breakup by Application
- Musculoskeletal
- Cardiovascular
- OB/GYN
- General Imaging
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ultrasound Transducer Market Share
Cardiovascular Imaging Likely to Dominate the Market Segment by Application
Cardiovascular imaging segment is likely to dominate with around 29% market share during the forecast period. Rising prevalence of cardiovascular diseases, increasing demand for early diagnosis, and technological advancements in imaging systems are key supporting factors. Growing adoption of echocardiography probes further enhances clinical accuracy, improving cardiac assessment efficiency across healthcare facilities globally in the forecast period.Ultrasound Transducer Market Analysis by Region
Asia-Pacific region is likely to dominate the market with about 32% market share during the forecast period. Growth is driven by expanding healthcare infrastructure, rising diagnostic imaging demand, and increasing patient population. Rapid adoption of medical imaging devices across emerging economies strengthens diagnostic capabilities, supporting improved clinical outcomes and enhanced healthcare accessibility across the region in the forecast period.Leading Players in the Ultrasound Transducer Market
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Koninklijke Philips N.V.
Founded in 1891 and headquartered in Amsterdam, Netherlands, Koninklijke Philips N.V. is a leading healthcare technology company specializing in advanced diagnostic imaging solutions. Its portfolio includes high-performance ultrasound transducers integrated with AI-enabled imaging systems for cardiology, obstetrics, and general imaging applications. The company focuses on enhancing diagnostic accuracy, workflow efficiency, and real-time imaging capabilities, strengthening its position in the global ultrasound transducer market through continuous innovation and digital healthcare integration.Founded in 1891 and headquartered in Amsterdam, Netherlands, Koninklijke Philips N.V. is a leading healthcare technology company specializing in advanced diagnostic imaging solutions. Its portfolio includes high-performance ultrasound transducers integrated with AI-enabled imaging systems for cardiology, obstetrics, and general imaging applications. The company focuses on enhancing diagnostic accuracy, workflow efficiency, and real-time imaging capabilities, strengthening its position in the global ultrasound transducer market through continuous innovation and digital healthcare integration.
Siemens Healthineers
Headquartered in Erlangen, Germany, and established in 2017 as a subsidiary of Siemens AG, Siemens Healthineers is a major provider of diagnostic imaging technologies. Its portfolio includes advanced ultrasound transducers designed for cardiovascular, musculoskeletal, and women’s health imaging applications. The company emphasizes AI-powered imaging, automation, and precision diagnostics to improve clinical outcomes. Its strong global presence and continuous investment in imaging innovation support its leadership in the ultrasound transducer market.Headquartered in Erlangen, Germany, and established in 2017 as a subsidiary of Siemens AG, Siemens Healthineers is a major provider of diagnostic imaging technologies. Its portfolio includes advanced ultrasound transducers designed for cardiovascular, musculoskeletal, and women’s health imaging applications. The company emphasizes AI-powered imaging, automation, and precision diagnostics to improve clinical outcomes. Its strong global presence and continuous investment in imaging innovation support its leadership in the ultrasound transducer market.
GE Healthcare
Founded in 1994 and headquartered in Chicago, Illinois, GE Healthcare is a global leader in medical imaging and healthcare technologies. The company offers a broad portfolio of ultrasound transducers and portable imaging systems used across cardiology, emergency care, and obstetrics applications. GE Healthcare focuses on improving image clarity, portability, and AI-assisted diagnostics to enhance patient care. Its continuous technological advancements and extensive healthcare network contribute significantly to growth in the market.Founded in 1994 and headquartered in Chicago, Illinois, GE Healthcare is a global leader in medical imaging and healthcare technologies. The company offers a broad portfolio of ultrasound transducers and portable imaging systems used across cardiology, emergency care, and obstetrics applications. GE Healthcare focuses on improving image clarity, portability, and AI-assisted diagnostics to enhance patient care. Its continuous technological advancements and extensive healthcare network contribute significantly to growth in the market.
Hitachi Medical Systems
Headquartered in Tokyo, Japan, Hitachi Medical Systems is recognized for its expertise in diagnostic imaging technologies and ultrasound systems. The company provides advanced ultrasound transducers for abdominal, cardiovascular, and musculoskeletal imaging applications. Its focus on high-resolution imaging, ergonomic device design, and minimally invasive diagnostic support strengthens its market presence. Continuous innovation in imaging performance and clinical efficiency supports the company’s contribution to the market.Other key players in the market include FUJIFILM Sonosite Inc., Shenzhen Mindray Bio-Medical Electronics Co., Canon Medical Systems Corporation, Samsung Medison Co., Ltd., and ESAOTE SPA.
Key Questions Answered in the Ultrasound Transducer Market Report
- What was the ultrasound transducer market value in 2025?
- What is the ultrasound transducer market forecast outlook for 2026-2035?
- What major factors aid the demand for the ultrasound transducer market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major ultrasound transducer market trends?
- Which product is expected to dominate the market segment?
- Which application is expected to dominate the market segment?
- Which end user is expected to dominate the market segment?
- Who are the key players in the ultrasound transducer market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
Companies Mentioned
- Koninklijke Philips N.V.
- Siemens Healthineers
- GE Healthcare
- Hitachi Medical Systems

